These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7214757)

  • 41. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
    Beck TR; Hassid A; Dunn MJ
    J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ionised and total serum magnesium in renal transplant patients.
    Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
    J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does cyclosporine inhibit renal prostaglandin synthesis?
    Adu D; Lote CJ; Michael J; Turney JH; McMaster P
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():969-72. PubMed ID: 3887392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidiuresis and inhibition of PGE2 excretion by hyperoxia in the conscious dog.
    Walker BR; Attallah AA; Lee JB; Hong SK; Mookerjee BK; Share L; Krasney JA
    Undersea Biomed Res; 1980 Jun; 7(2):113-26. PubMed ID: 7404849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of dexamethasone on rabbit renal prostaglandin E2 excretion: dependence on urinary flow.
    Attallah A
    Eur J Pharmacol; 1987 May; 137(1):139-41. PubMed ID: 3475208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The concentration of prostaglandin E2 in human periradicular lesions.
    McNicholas S; Torabinejad M; Blankenship J; Bakland L
    J Endod; 1991 Mar; 17(3):97-100. PubMed ID: 1940730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radioimmunoassay of the main urinary metabolite of prostaglandin F2 alpha in normal subjects after oral administration of prostaglandins E2 and F2 alpha.
    Kitamura S; Ishihara Y
    Adv Prostaglandin Thromboxane Res; 1980; 6():213-7. PubMed ID: 7386260
    [No Abstract]   [Full Text] [Related]  

  • 49. The importance of age on prostaglandin E2 excretion in normal and hypertensive men.
    Mackenzie T; Zawada ET; Johnson MD; Green S
    Nephron; 1984; 38(3):178-82. PubMed ID: 6593599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation between renal medullary PGE2-synthesis and urine PGE2-excretion. Antagonism by bumetanide of chlorazanil induced urine PGE2-excretion in rats.
    Olsen UB
    Prostaglandins; 1981 Apr; 21(4):591-7. PubMed ID: 7255744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary prostaglandins in kidney disease.
    Papanicolaou N; Mountokalakis T; Palassides A; Paris M; Bariety J; Papavassiliou J; Merikas G; Milliez P
    Prostaglandins Med; 1979 Jul; 3(1):47-51. PubMed ID: 552098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on urinary kallikrein excretion in obstructive renal diseases].
    Nakajima H; Kumamoto Y; Shimamoto K; Iimura O
    Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):126-37. PubMed ID: 6588216
    [No Abstract]   [Full Text] [Related]  

  • 53. Study of the role of prostaglandin E2 in urine flow regulation in chronic renal failure.
    Natochin YV; Bogolepova AE; Kuznetsova AA; Shakhmatova EI
    Scand J Urol Nephrol; 2000 Oct; 34(5):327-30. PubMed ID: 11186473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PGE2 concentrations in renal venous plasma and renal lymph during basal and stimulated conditions in the dog.
    Hohenfellner RM; Rehbock J; Brechtelsbauer H; Klein HG; Thurau K
    Pflugers Arch; 1989 Apr; 413(6):673-5. PubMed ID: 2726430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?
    de Jong PE; Saleh AW; de Zeeuw D; Donker AJ; van der Hem GK; Pratt JJ; Sewrajsingh GS; Statius van Eps LW
    Clin Nephrol; 1984 Oct; 22(4):212-3. PubMed ID: 6595096
    [No Abstract]   [Full Text] [Related]  

  • 56. [Metabolic criteria of the effective treatment of acute renal failure with prostaglandin E2].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Anesteziol Reanimatol; 1985; (1):34-6. PubMed ID: 3857873
    [No Abstract]   [Full Text] [Related]  

  • 57. Renal prostaglandin E in primary aldosteronism.
    Hsieh BS; Chen WY; Yen TS; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1982 Aug; 81(8):979-85. PubMed ID: 6960139
    [No Abstract]   [Full Text] [Related]  

  • 58. Human benign prostatic hypertrophy: role of prostaglandin E2 and its relationships to bromocriptine therapy.
    Rolland PH; Martin PM; Serment G; Roulier R; Rolland AM
    Eur Urol; 1981; 7(1):41-5. PubMed ID: 6161821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal infection with hypercalcemia and increased prostaglandin excretion.
    Hsieh BS; Chen WY; Yen TS; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1980 Dec; 79(12):1071-6. PubMed ID: 6267159
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental treatment of acute renal insufficiency with prostaglandin E2].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Patol Fiziol Eksp Ter; 1986; (3):67-9. PubMed ID: 3462649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.